Fundraising Fox
Paul Schimmel
InvestorFounderProfessor of Biochemistry and Biophysics at MIT at Cardinal Partners · Founder at aTYR PHARMA
FoundedaTYR PHARMA
Find your path to Paul
Sign up to see every warm intro you have to Paul
- Paths you didn't know you had: your email and LinkedIn already hold routes to Paul. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Paul Schimmel is the Ernest and Jean Hahn Professor of Cell and Molecular Biology at The Scripps Research Institute, with campuses in Florida and California. He earned his PhD in biochemistry and biophysics from MIT in 1966 and previously held the John D. and Catherine T. MacArthur Professorship in MIT's Department of Biology. He has authored roughly 500 scientific papers and a three-volume textbook on biophysical chemistry, holds numerous patents, and has cofounded or served as founding director of several biotechnology companies, seven of which became NASDAQ-listed.
Invests in
Biotech
Founder at aTYR PHARMA
Intro paths
In turn, Paul can intro founders to aTYR PHARMA's investors below.
aTYR PHARMA's investors · 9
Deals · 1
aTYR PHARMABoard seat
via Cardinal Partners · filed Sep 2017 · $45.8M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Cardinal Partners
Frequently asked questions
- Who is Paul Schimmel?
- Paul Schimmel is the Ernest and Jean Hahn Professor of Cell and Molecular Biology at The Scripps Research Institute, with campuses in Florida and California. He earned his PhD in biochemistry and biophysics from MIT in 1966 and previously held the John D. and Catherine T. MacArthur Professorship in MIT's Department of Biology. He has authored roughly 500 scientific papers and a three-volume textbook on biophysical chemistry, holds numerous patents, and has cofounded or served as founding director of several biotechnology companies, seven of which became NASDAQ-listed.
- Where does Paul Schimmel work?
- Paul Schimmel is Founder of aTYR PHARMA and Professor of Biochemistry and Biophysics at MIT at Cardinal Partners.
- What does Paul Schimmel invest in?
- Paul Schimmel invests in Biotech.
- What companies did Paul Schimmel found?
- Paul Schimmel founded aTYR PHARMA.
- What boards does Paul Schimmel sit on?
- Paul Schimmel holds tracked board seats at aTYR PHARMA.
About this profile. Compiled from public sources — Cardinal Partners's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights